The Role of Calcitonin and Vitamin D in patients with Chronic Renal Failure and Arthritis
Article Sidebar
Main Article Content
Abstract
Background: Chronic kidney disease is an end stage leads to problems in bone as rheumatoid arthritis (RA) with both glomerular and tubular damage. It is often difficult to differentiate between damage due to disease activity and that due to drugs used to treat Rheumatoid Arthritis.
The aim: To estimate the levels of Calcitonin and Vitamin D and their relationship with renal Osteodystrophy
Methods: Calcitonin and Vitamin D were obtained from 135samples: 85 samples from patients with chronic renal failure, 25 samples with (CRF with arthritis) renal Osteodystrophy, and 25 samples apparently healthy .
Results: A highly significant increase (p<0. 001) in the level of calcitonin in serum of patients with Chronic renal failure and renal osteodystrophy disease compared with healthy individuals. Highly significant decrease (p<0. 001) in the level of vitamin D in serum of patients with chronic renal failure and renal osteodystrophy disease compared with healthy individuals.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. National institute for health and care excellence, Chronic kidney disease, early identification and management of chronic kidney disease in adults in primary and secondary, Care, July( 2014), NICE clinical guideline 182,p _4.
2.Song Li, Yangsheng Yu, Christopher D Koehn, Zhixin Zhang and Kaihong Su ,, Galectins in the Pathogenesis of Rheumatoid Arthritis, J Clin Cell Immunol 2013, 4:5.
3.. Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm (2007);13: 397–411.
4.C. Pierre-Jerome, V. Moncayo, M. R. Terk; Atlanta, Renal Osteodystrophy Revisited: A Didactic Review Of Imaging, Pathophysiology, And Differential Diagnosis, Doi: 10.1594/Ecr (2010),C-2174
5. Laura Masi and Maria Luisa Brandi Calcitonin and calcitonin receptors, Clinical Cases in Mineral and Bone Metabolism 2007; 4(2): 117-122.
6. Carr, J., & Norris, D. (2013). Vertebrate Endocrinology. Walthman, MA: Elsevier Inc.
7.Szkudinski, M. Thyroid Stimulating Hormone and Thyroid Stimulating Hormone Receptor Structure and Function. Vol. 82 473‐502 Retrieved 19 January (2014) from OLPC
8. Christoph Guesgen, Arnulf Willms, Axel Zwad1, Stephan Waldeck, Helmut Wieler and Robert Schwab, Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a
cautionary note, BMC Clinical Pathology (2013), 13:27.
9. Barwell, J., et.all. (2012). Calcitonin and Calcitonin Receptor‐like Receptors: Common Themes with Family B GPCRs. US National Library of Medicine & National Institutes of Health, 51‐65.
10. Holick MF. Vitamin D deficiency. N Engl J Med.( 2007);357:266-281.
11. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr.(2004); 80:1689S-1696S.
12. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol. 2005;97:103-109.
13. Norman AW. A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr. (2008);88:1455-1456.
14. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. (2009);94:26-34.
15. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. (2008); 76:3837-3843.
16.Mohr SB. A brief history of vitamin d and cancer prevention. Ann Epidemiol.( 2009);19:79-83.
17. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observational study. Am J Nephrol( 2004), 24(5):503–510.
18. Holick MF: Vitamin D for health and in chronic kidney disease. Semin Dial (2005), 18(4):266–275.
19. Caitlin C Hesketh, Greg A Knoll, Amber O Molnar, Anne Tsampalieros and Deborah L Zimmerman, Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis, BIO MeD Central.2014.
20. Holick, M.F., 2007. Vitamin D deficiency. New. Eng. J. Med., 357: 266-281.
21. Firas Sultan Azzeh, Relationship Between Vitamin D and Rheumatoid Arthritis Disease, Pakistan Journal of Nutrition (2012),11 (3): 293-300,.
22. Human calcitonin (CT)ELISA Kit .Cusabio biotech Co., LTD. ,Catalog Number .CSB-E05131h.
23. L iason ® 25 OH Vitamin D Total assay DiaSorin Inc. Northwestern Ave -Stillwater, MN 55082-550285.
24. Dusso, A.; Gonzalez, E.A.; Martin, K.J. Vitamin d in chronic kidney disease. Best Pract. Res. Clin. Endocrinol. Metab. (2011), 25, 647–655.
25. Urena-Torres, P.; Metzger, M.; Haymann, J.P.; Karras, A.; Boffa, J.J.; Flamant, M.; Vrtovsnik, F.; Gauci, C.; Froissart, M.; Houillier, P.; et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am. J. Kidney Dis.( 2011), 58, 544–553.
26. Zhao-Min Liu, Jean Woo, Sheng-Hui Wu, and Suzanne C. Ho, The Role of Vitamin D in Blood Pressure, Endothelial and Renal Function in Postmenopausal Women, Nutrients 2013, 5, 2590-2610; doi: 10. 3390/ nu5072590.
27. Shoben, A.B.; Rudser, K.D.; de Boer, I.H.; Young, B.; Kestenbaum, B. Association of oral calcitriol with improved survival in nondialyzed ckd. J. Am. Soc. Nephrol. 2008, 19, 1613–1619.
28. Rajeev Sharma , Renu Saigal , Laxmikant Goyal, Pradeep Mital, RN Yadav, PD Meena, Abhishek Agrawal, Estimation of Vitamin D Levels in Rheumatoid Arthritis Patients and its Correlation with the Disease Activity, Journal of the association of physicians of india, JAPI, (2014), VOL.62 .
29. Aisha Yassin, Hala Gareeb, 1Nesrine A Mohamed, Caroline Samy, The Relationship between Vitamin D and Disease Activity in Egyptian Patients with Rheumatoid Arthritis, international trends in immunity ,July( 2014),VOL.2, NO.3.
30. Diaz VA, Mainous AG, Carek PJ, Wessell AM, Everett CJ. The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health Disparities. J Am Board Fam, (2009); 22:521–527.
31. Zhang et al., Management of Metabolic Bone Disease in Kidney Transplant Recipients., the american journal of the medical sciences, February (2008) Volume 335 Number 2.
32. Laura Masi, Maria Luisa Brandi, Calcitonin and calcitonin receptors, Clin Cases Miner Bone Metab. (2007 )May-Aug; 4(2): 117–122.
33. Farag S.E., Functional and Morphological Thyroid Disorders in Hemodialysis Patients, Thyroid Disorders There (2013), 2(1), 1-4.